Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism SIRPα modulators(Signal-regulatory protein alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | South Korea | 01 Mar 2026 | |
| Inflammation | Preclinical | South Korea | 01 Mar 2026 |





